Non Small Cell Lung Cancer (NSCLC) – Robert Figlin, MD, and Melissa Johnson, MD, discuss the different driver mutations in non small cell lung cancer (NSCLC)

Share:

OBR Peer-Spectives

Miscellaneous

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center speaks with Melissa Johnson, MD, Program Director, Lung Cancer Research, Sarah Cannon Research Institute, discuss the different driver mutations in Non Small Cell Lung Cancer (NSCLC) and how to use them to guide treatment